_id
69105c47ccc777a4e85d584d
Ticker
DOCS
Name
Doximity Inc
Exchange
NYSE
Address
500 3rd Street, San Francisco, CA, United States, 94107
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.doximity.com
Description
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Last Close
43.85
Volume
563884
Current Price
44.65
Change
1.8244013683010196
Last Updated
2025-11-29T12:20:08.173Z
Image
-
Ipo Date
2021-06-24T00:00:00.000Z
Market Cap
9684673536
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9757526315789472
Sentiment Sources
38
Rating
3.6842
Target Price
68.5263
Strong Buy
5
Buy
3
Hold
11
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
168525000
Cost Of Revenue
16425000
Gross Profit
152100000
Operating Expenses
88419000
Operating Income
63681000
Interest Expense
-
Pretax Income
72939000
Net Income
62059000
Eps
0.3091434406834541
Dividends Per Share
-
Shares Outstanding
137373858
Income Tax Expense
10880000
EBITDA
78108000
Operating Margin
37.78727191811304
Total Other Income Expense Net
9258000
Cash
169249000
Short Term Investments
709118000
Receivables
129306000
Inventories
-
Total Current Assets
1092200000
Property Plant Equipment
23694000
Total Assets
1257109000
Payables
4391000
Short Term Debt
2123000
Long Term Debt
-
Total Liabilities
161578000
Equity
1095531000
Depreciation
6345000
Change In Working Capital
16926000
Cash From Operations
93944000
Capital Expenditures
2369000
Cash From Investing
-31711000
Cash From Financing
-30245000
Net Change In Cash
31988000
PE
41.152
PB
8.181661906417984
ROE
5.664741572808072
ROA
4.936644316443522
FCF
91575000
Fcf Percent
0.5433911882510013
Piotroski FScore
4
Health Score
71
Deep Value Investing Score
5.5
Defensive Investing Score
8
Dividend Investing Score
3
Economic Moat Investing Score
9.5
Garp Investing Score
6
Growth Investing Score
5
Momentum Investing Score
5
Net Net Investing Score
4
Quality Investing Score
8.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
168525000
Quarters > 0 > income Statement > cost Of Revenue
16425000
Quarters > 0 > income Statement > gross Profit
152100000
Quarters > 0 > income Statement > operating Expenses
88419000
Quarters > 0 > income Statement > operating Income
63681000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
72939000
Quarters > 0 > income Statement > net Income
62059000
Quarters > 0 > income Statement > eps
0.3091434406834541
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
200745000
Quarters > 0 > income Statement > income Tax Expense
10880000
Quarters > 0 > income Statement > EBITDA
78108000
Quarters > 0 > income Statement > operating Margin
37.78727191811304
Quarters > 0 > income Statement > total Other Income Expense Net
9258000
Quarters > 0 > balance Sheet > cash
169249000
Quarters > 0 > balance Sheet > short Term Investments
709118000
Quarters > 0 > balance Sheet > receivables
129306000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1092200000
Quarters > 0 > balance Sheet > property Plant Equipment
23694000
Quarters > 0 > balance Sheet > total Assets
1257109000
Quarters > 0 > balance Sheet > payables
4391000
Quarters > 0 > balance Sheet > short Term Debt
2123000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
161578000
Quarters > 0 > balance Sheet > equity
1095531000
Quarters > 0 > cash Flow > net Income
62059000
Quarters > 0 > cash Flow > depreciation
6345000
Quarters > 0 > cash Flow > change In Working Capital
16926000
Quarters > 0 > cash Flow > cash From Operations
93944000
Quarters > 0 > cash Flow > capital Expenditures
2369000
Quarters > 0 > cash Flow > cash From Investing
-31711000
Quarters > 0 > cash Flow > cash From Financing
-30245000
Quarters > 0 > cash Flow > net Change In Cash
31988000
Quarters > 0 > ratios > PE
0.3091434406834541
Quarters > 0 > ratios > PB
8.181661906417984
Quarters > 0 > ratios > ROE
5.664741572808072
Quarters > 0 > ratios > ROA
4.936644316443522
Quarters > 0 > ratios > FCF
91575000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.5433911882510013
Quarters > 0 > health Score
71
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
145913000
Quarters > 1 > income Statement > cost Of Revenue
15793000
Quarters > 1 > income Statement > gross Profit
130120000
Quarters > 1 > income Statement > operating Expenses
75603000
Quarters > 1 > income Statement > operating Income
54517000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
64147000
Quarters > 1 > income Statement > net Income
53320000
Quarters > 1 > income Statement > eps
0.26506527207468755
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
201158000
Quarters > 1 > income Statement > income Tax Expense
10827000
Quarters > 1 > income Statement > EBITDA
66941000
Quarters > 1 > income Statement > operating Margin
37.36267501867551
Quarters > 1 > income Statement > total Other Income Expense Net
9630000
Quarters > 1 > balance Sheet > cash
137261000
Quarters > 1 > balance Sheet > short Term Investments
703712000
Quarters > 1 > balance Sheet > receivables
141663000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1034231000
Quarters > 1 > balance Sheet > property Plant Equipment
22711000
Quarters > 1 > balance Sheet > total Assets
1204447000
Quarters > 1 > balance Sheet > payables
1962000
Quarters > 1 > balance Sheet > short Term Debt
2168000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
178852000
Quarters > 1 > balance Sheet > equity
1025595000
Quarters > 1 > cash Flow > net Income
53320000
Quarters > 1 > cash Flow > depreciation
2794000
Quarters > 1 > cash Flow > change In Working Capital
-17328000
Quarters > 1 > cash Flow > cash From Operations
62101000
Quarters > 1 > cash Flow > capital Expenditures
1966000
Quarters > 1 > cash Flow > cash From Investing
2679000
Quarters > 1 > cash Flow > cash From Financing
-137133000
Quarters > 1 > cash Flow > net Change In Cash
-72353000
Quarters > 1 > ratios > PE
0.26506527207468755
Quarters > 1 > ratios > PB
8.757555077784115
Quarters > 1 > ratios > ROE
5.198933302131933
Quarters > 1 > ratios > ROA
4.426927876444543
Quarters > 1 > ratios > FCF
60135000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.41212914544968576
Quarters > 1 > health Score
70
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
138288000
Quarters > 2 > income Statement > cost Of Revenue
14467000
Quarters > 2 > income Statement > gross Profit
123821000
Quarters > 2 > income Statement > operating Expenses
75141000
Quarters > 2 > income Statement > operating Income
48680000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
58394000
Quarters > 2 > income Statement > net Income
62458000
Quarters > 2 > income Statement > eps
0.3076945814263968
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
202987000
Quarters > 2 > income Statement > income Tax Expense
-4064000
Quarters > 2 > income Statement > EBITDA
51509000
Quarters > 2 > income Statement > operating Margin
35.20189748929769
Quarters > 2 > income Statement > total Other Income Expense Net
9714000
Quarters > 2 > balance Sheet > cash
209614000
Quarters > 2 > balance Sheet > short Term Investments
706050000
Quarters > 2 > balance Sheet > receivables
128354000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1088620000
Quarters > 2 > balance Sheet > property Plant Equipment
22542000
Quarters > 2 > balance Sheet > total Assets
1264309000
Quarters > 2 > balance Sheet > payables
1356000
Quarters > 2 > balance Sheet > short Term Debt
2211000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
181684000
Quarters > 2 > balance Sheet > equity
1082625000
Quarters > 2 > cash Flow > net Income
62458000
Quarters > 2 > cash Flow > depreciation
2829000
Quarters > 2 > cash Flow > change In Working Capital
27997000
Quarters > 2 > cash Flow > cash From Operations
98487000
Quarters > 2 > cash Flow > capital Expenditures
1507000
Quarters > 2 > cash Flow > cash From Investing
-24473000
Quarters > 2 > cash Flow > cash From Financing
-29670000
Quarters > 2 > cash Flow > net Change In Cash
44344000
Quarters > 2 > ratios > PE
0.3076945814263968
Quarters > 2 > ratios > PB
8.371661055305392
Quarters > 2 > ratios > ROE
5.769125966978409
Quarters > 2 > ratios > ROA
4.9400898039957
Quarters > 2 > ratios > FCF
96980000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.7012900613213005
Quarters > 2 > health Score
71
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
168603000
Quarters > 3 > income Statement > cost Of Revenue
14181000
Quarters > 3 > income Statement > gross Profit
154422000
Quarters > 3 > income Statement > operating Expenses
74497000
Quarters > 3 > income Statement > operating Income
79925000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
89840000
Quarters > 3 > income Statement > net Income
75196000
Quarters > 3 > income Statement > eps
0.3718285344132758
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
202233000
Quarters > 3 > income Statement > income Tax Expense
14644000
Quarters > 3 > income Statement > EBITDA
82580000
Quarters > 3 > income Statement > operating Margin
47.40425733824428
Quarters > 3 > income Statement > total Other Income Expense Net
9915000
Quarters > 3 > balance Sheet > cash
165270000
Quarters > 3 > balance Sheet > short Term Investments
679670000
Quarters > 3 > balance Sheet > receivables
137504000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1012703000
Quarters > 3 > balance Sheet > property Plant Equipment
22809000
Quarters > 3 > balance Sheet > total Assets
1172157000
Quarters > 3 > balance Sheet > payables
1636000
Quarters > 3 > balance Sheet > short Term Debt
2255000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
141037000
Quarters > 3 > balance Sheet > equity
1031120000
Quarters > 3 > cash Flow > net Income
75196000
Quarters > 3 > cash Flow > depreciation
2655000
Quarters > 3 > cash Flow > change In Working Capital
18803000
Quarters > 3 > cash Flow > cash From Operations
65189000
Quarters > 3 > cash Flow > capital Expenditures
1771000
Quarters > 3 > cash Flow > cash From Investing
-58924000
Quarters > 3 > cash Flow > cash From Financing
-25243000
Quarters > 3 > cash Flow > net Change In Cash
-18978000
Quarters > 3 > ratios > PE
0.3718285344132758
Quarters > 3 > ratios > PB
8.75718000814648
Quarters > 3 > ratios > ROE
7.292652649546125
Quarters > 3 > ratios > ROA
6.415181584036951
Quarters > 3 > ratios > FCF
63418000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.376138028386209
Quarters > 3 > health Score
72
Valuation > metrics > PE
41.152
Valuation > metrics > PB
8.181661906417984
Valuation > final Score
1
Valuation > verdict
118.7% Overvalued
Profitability > metrics > ROE
5.664741572808072
Profitability > metrics > ROA
5.68201794543124
Profitability > metrics > Net Margin
0.3682480344162587
Profitability > final Score
58
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.1474882956301556
Risk > metrics > Interest Coverage
12.319791062100986
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
167.66963463309796
Liquidity > metrics > Quick Ratio
167.66963463309796
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
56
Prev Profitabilities > 1
59
Prev Profitabilities > 2
67
Prev Risks > 0
100
Prev Risks > 1
88
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:34:24.700Z
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A3 New Year’s Resolution Stocks That Could Turn Around in 2026 MarketBeat
Read more →Why analysts remain bullish on DOCS stock - July 2025 Short Interest & High Return Trade Guides Улправда
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$68.5263
Analyst Picks
Strong Buy
5
Buy
3
Hold
11
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 66.03% of the total shares of Doximity Inc
1.
BlackRock Inc(7.9717%)
since
2025/06/30
2.
Vanguard Group Inc(6.8077%)
since
2025/06/30
3.
FMR Inc(5.9242%)
since
2025/06/30
4.
William Blair Investment Management, LLC(2.7867%)
since
2025/06/30
5.
ClearBridge Advisors, LLC(2.7698%)
since
2025/06/30
6.
iShares Core S&P Mid-Cap ETF(2.3201%)
since
2025/08/31
7.
Capital World Investors(2.2849%)
since
2025/06/30
8.
State Street Corp(2.1515%)
since
2025/06/30
9.
Baillie Gifford & Co Limited.(2.1004%)
since
2025/06/30
10.
Vanguard Total Stock Mkt Idx Inv(2.0739%)
since
2025/07/31
11.
Geode Capital Management, LLC(1.9434%)
since
2025/06/30
12.
Franklin Resources Inc(1.6885%)
since
2025/06/30
13.
Vanguard Small Cap Index(1.5966%)
since
2025/07/31
14.
Capital Group Growth Fnd of Amer Comp(1.5088%)
since
2025/06/30
15.
American Funds Growth Fund of Amer A(1.5088%)
since
2025/06/30
16.
Loomis, Sayles & Company LP(1.2523%)
since
2025/06/30
17.
Vanguard Explorer Inv(1.2238%)
since
2025/06/30
18.
Renaissance Technologies Corp(1.1829%)
since
2025/06/30
19.
Franklin Innovation Composite(1.1291%)
since
2025/06/30
20.
Baillie Gifford US Equity Growth(1.1286%)
since
2024/12/31
21.
Franklin DynaTech A(1.0678%)
since
2025/07/31
22.
Vanguard US Growth Investor(1.0138%)
since
2025/06/30
23.
Amvescap Plc.(1.0114%)
since
2025/06/30
24.
UBS Asset Mgmt Americas Inc(0.9916%)
since
2025/06/30
25.
Vanguard Small Cap Growth Index Inv(0.9003%)
since
2025/07/31
26.
HHG PLC(0.8259%)
since
2025/06/30
27.
Northern Trust Corp(0.767%)
since
2025/06/30
28.
Vanguard Institutional Extnd Mkt Idx Tr(0.7664%)
since
2025/07/31
29.
American Funds SMALLCAP World A(0.7398%)
since
2025/06/30
30.
Fundsmith LLP(0.7239%)
since
2025/06/30
31.
Smithson Investment Trust Ord(0.7239%)
since
2025/05/31
32.
Morgan Stanley - Brokerage Accounts(0.6948%)
since
2025/06/30
33.
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)(0.689%)
since
2025/06/30
34.
Dimensional Fund Advisors, Inc.(0.6659%)
since
2025/06/30
35.
Fidelity(0.5887%)
since
2025/06/30
36.
SPDR® S&P MIDCAP 400 ETF Trust(0.546%)
since
2025/07/31
37.
William Blair SMID Growth CIT 1(0.4942%)
since
2025/07/31
38.
William Blair SMID Growth CIT 5(0.4942%)
since
2025/07/31
39.
Baillie Gifford American B Inc(0.4883%)
since
2025/07/31
40.
ClearBridge Growth(0.4846%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.